𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical monitoring with fuzzy automata

✍ Scribed by Friedrich Steimann; Klaus-Peter Adlassnig


Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
425 KB
Volume
61
Category
Article
ISSN
0165-0114

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Design of clinical trials for recurrent
✍ Shigeyuki Matsui; Hideaki Miyagishi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

This paper presents a design for randomized clinical trials in which incomplete data are collected on the occurrence of potentially recurrent events through periodic monitoring. In particular, events are assumed to arise according to a point process, but information is available at the times of moni

Inference for a RPW-Type Clinical Trial
✍ Atanu Biswas; Anup Dewanji πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 1 views

## Abstract The present paper describes a controlled clinical trial to investigate the effect of Pulsed Electro‐Magnetic Field for the treatment of sequentially entering patients with Rheumatoid Arthritis. According to the study design, repeated monitorings of the patients are carried out to assess

Clinical usefulness of therapeutic drug
✍ Melissa L. Haines; Yousef Ajlouni; Peter M. Irving; Miles P. Sparrow; Rosemary R πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

Background: Circulating concentrations of 6-thioguanine nucleotide (6-TGN) and 6-methyl mercaptopurine (6-MMP) are associated with thiopurine efficacy and may predict toxicity. This study aimed to examine retrospectively the utility of measuring metabolite concentrations in patients with inflammator

Molecular diagnosis and monitoring in th
✍ Joyce Ou; Jo-Anne Vergilio; Adam Bagg πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 161 KB πŸ‘ 2 views

## Abstract The well‐established molecular pathogenesis of chronic myelogenous leukemia (CML) and its consequences for laboratory testing and clinical management illustrate a classic paradigm for the importance of molecular diagnostics in targeted drug therapy. The success of the tyrosine kinase in